Carcinoembryonic antigen (CEA) in stage IV gastric cancer as a risk factor for liver metastasis: A univariate and multivariate analysis

Yoichi Ikeda, Masaki Mori, Yosuke Adachi, Tetsuya Matsushima, Keizo Sugimachi, Motonori Saku

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Serum carcinoembryonic antigen (CEA) levels were determined in 68 patients with Stage IV gastric cancers, the objective being to examine the clinicopathological relationship between the metastatic patterns of gastric cancer and the serum CEA level. Of the 68 patients, 31 were diagnosed as cases of liver metastases and 37 as cases of peritoneal dissemination. Serum CEA levels were elevated in 21 of 31 patients (67.8%) with liver metastases and in 7 of 37 patients (18.9%) with peritoneal dissemination (P < 0.01). A univariate analysis showed that liver metastasis correlated with a young age (P < 0.01), the lower portion of stomach (P < 0.05), Borrmann types 1 and 2 (P < 0.01), differentiated type (P < 0.01), and nonserosal involvement (P < 0.05) more than did peritoneal dissemination. A multivariate analysis showed that in addition to Borrmann type 1 and 2, elevated CEA levels (>2.5 ng/ml) is an independent risk factor involved in liver metastasis. Thus careful follow‐up and postoperative adjuvant therapy are required for patients with elevated CEA levels, even with “curative” resection. © 1993 Wiley‐Liss, Inc.

Original languageEnglish
Pages (from-to)235-238
Number of pages4
JournalJournal of Surgical Oncology
Volume53
Issue number4
DOIs
Publication statusPublished - Aug 1993

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Carcinoembryonic antigen (CEA) in stage IV gastric cancer as a risk factor for liver metastasis: A univariate and multivariate analysis'. Together they form a unique fingerprint.

  • Cite this